(Q56412386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

editorial

0 references

title

Clinical implications of hemodialysis membrane biocompatibility (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

R M Hakim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

484-494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1993.272

27 October 2019

exact match

0 references

cites work

Dialysis membrane biocompatibility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Are there long-term clinical consequences related to membrane biocompatibility?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Compartmental distribution of complement activation products in artificial kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Cytokines and biocompatibility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Blood-membrane interaction in hemodialysis leads to increased cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Hemodialysis-associated platelet activation and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Profound Neutropenia During the Early Phase of Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Anaphylatoxin formation in extracorporeal circuits

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Biocompatibility of dialysis membranes: Effects of chronic complement activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Cardiopulmonary effects of cuprophane-activated plasma in the swine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

The effect of dialyzer reuse on peak expiratory flow rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Multiple use of dialyzers: safety and efficacy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer use

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Complement Activation and Hypersensitivity Reactions to Dialysis Membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Allergy to ethylene oxide in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Beta 2-microglobulin amyloidosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Beta-2-microglobulin amyloidosis in long-term dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Carpal tunnel syndrome and type of dialysis membrane

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Beta 2-microglobulin deposition in bone in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Distribution of 'free' and HLA-associated human beta 2-microglobulin in some plasma membranes and biological fluids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Stimulation of beta 2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Effects of dialysis membranes on beta 2-microglobulin production and cellular expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Beta 2-microglobulin kinetics in end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Mortality in dialysis patients: analysis of the causes of death

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Respective Influence of Uremia and Hemodialysis on Whole Blood Phagocyte Oxidative Metabolism, and Circulating Interleukin-1 and Tumor Necrosis Factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Cell-surface Receptor Shedding: A Means of Regulating Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Differential activation of monocytes in haemodialysis patients exposed to different types of membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Functional changes of monocytes due to dialysis membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Impaired function of macrophage Fc gamma receptors in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Differential effect of hemodialysis membranes on human lymphocyte natural killer function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Effect of hemodialysis membranes on human lymphocyte natural killer function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Mixed lymphocyte reaction-induced release of soluble IL-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Impaired Humoral and Cell-Mediated Immune Responses in Dialyzed Patients after Influenza Vaccination

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Differences in vascular reactivity in models of ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Effect of leukocyte depletion on the function of the postobstructed kidney in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Mild renal ischemia activates primed neutrophils to cause acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Complement activation retards resolution of acute ischemic renal failure in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Malnutrition in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Adequacy of hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Fluid phase generation of terminal complement complex as a novel index of bioincompatibility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

On the kinetics of complement activation, leucopenia and granulocyte-elastase release induced by haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Systemic complement activation, lung injury, and products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.272

7 January 2021

Identifiers

DOI

10.1038/KI.1993.272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8231020%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 October 2019

1033096799

0 references

1 reference